Dr. Strumph is Vice President, Therapeutic Strategy Lead, Cardiovascular / Metabolic at Quintiles Transnational, a fully integrated bio pharmaceutical services company offering Clinical, Commercial, Consulting and Capital solutions worldwide.
He has led or co-led development teams responsible for first-in-human to post-approval phase IV studies with Bristol-Myers Squibb & Co., Merck KGaA, and GlaxoSmithKline. With over ten years of experience assuming roles of increasing responsibility in clinical research and development in diabetes and related fields, his perspectives have included small to large pharma based in and outside the U.S., device development, and non-profit clinical leadership at the Juvenile Diabetes Research Foundation.
Dr. Strumph is one of the few people who achieved certification in four board specialties: Internal Medicine, Pediatrics, Adult Endocrinology Diabetes and Metabolism, and Pediatric Endocrinology. He is an author of more than a dozen articles in scientific journals and magazines, including Nature, Clinical Pediatrics, The Journal of Clinical Endocrinology and Metabolism, and Diabetes Care.
|
